Literature DB >> 8460000

The sensitive period for strabismic amblyopia in humans.

M Epelbaum1, C Milleret, P Buisseret, J L Dufier.   

Abstract

PURPOSE: In order to assess the sensitive period for strabismic amblyopia, the period of susceptibility to monocular occlusion was investigated in 407 children who ranged in age from 21 months to 12 years.
METHODS: Patients were treated between 1975 and 1990 by occlusion of the best eye. The efficiency of the treatment was measured as the ratio of reduction of the amblyopia at the end of the occlusion.
RESULTS: The efficiency of the occlusion is shown to depend on the age of the onset of the treatment: recovery of acuity of the amblyopic eye was maximum when the occlusion was initiated before 3 years of age, decreased as a function of age and was about null by the time the patient was 12 years of age.
CONCLUSION: This is assumed to be an indication of the sensitive period for strabismic amblyopia in humans. The results are discussed on the basis of the neurophysiological mechanisms of amblyopia established in animals.

Entities:  

Mesh:

Year:  1993        PMID: 8460000     DOI: 10.1016/s0161-6420(13)32170-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  47 in total

1.  Amblyopia therapy.

Authors:  B W Fleck
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

2.  Efficacy of occlusion for strabismic amblyopia: can an optimal duration be identified?

Authors:  M Cleary
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

3.  Amblyopia treatment outcomes after preschool screening v school entry screening: observational data from a prospective cohort study.

Authors:  C Williams; K Northstone; R A Harrad; J M Sparrow; I Harvey
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

4.  Screening for visual impairment in children younger than age 5 years: recommendation statement.

Authors: 
Journal:  Ann Fam Med       Date:  2004 May-Jun       Impact factor: 5.166

5.  Movement hyperacuity in childhood amblyopia.

Authors:  S L Kelly; T J Buckingham
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

6.  Strabismus surgery before versus after completion of amblyopia therapy in children.

Authors:  Sanita Korah; Swetha Philip; Smitha Jasper; Aileen Antonio-Santos; Andrew Braganza
Journal:  Cochrane Database Syst Rev       Date:  2014-10-15

7.  Biometry: a tool for the detection of amblyopia risk factor in children.

Authors:  Tsukasa Satou; Takahiro Niida; Misae Ito
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-06-10       Impact factor: 3.117

Review 8.  The treatment of amblyopia: current practice and emerging trends.

Authors:  Eleni Papageorgiou; Ioannis Asproudis; Gail Maconachie; Evangelia E Tsironi; Irene Gottlob
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-01-31       Impact factor: 3.117

9.  Beyond Rehabilitation of Acuity, Ocular Alignment, and Binocularity in Infantile Strabismus.

Authors:  Chantal Milleret; Emmanuel Bui Quoc
Journal:  Front Syst Neurosci       Date:  2018-07-18

10.  Part-time occlusion therapy for amblyopia in older children.

Authors:  Inderpreet Singh; Nishant Sachdev; Gagandeep S Brar; Sushmita Kaushik
Journal:  Indian J Ophthalmol       Date:  2008 Nov-Dec       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.